Avalo Therapeutics (AVTX) Other Non Operating Income (2020 - 2025)
Avalo Therapeutics (AVTX) reported Other Non Operating Income of -$3000.0 for Q3 2025, up 40.0% on a YoY basis from -$2142.9 in Q3 2024, and up 40.0% quarter-over-quarter from -$5000.0 in Q2 2025.
Avalo Therapeutics (AVTX) Other Non Operating Income (2020 - 2025) Analysis & Trends
Avalo Therapeutics has reported Other Non Operating Income for 6 years, with the latest figure at -$3000.0 in Q3 2025.
- For the quarter ending Q3 2025, Other Non Operating Income rose 40.0% year-over-year to -$3000.0; the trailing twelve-month figure through Sep 2025 stood at -$13000.0 (up 72.34% YoY), and the FY2024 full-year result was -$5000.0, up 88.1% from the prior year.
- Other Non Operating Income for Q3 2025 stood at -$3000.0, up from -$5000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $78000.0 in Q4 2023, with the low at -$180000.0 in Q1 2023.
- Historically, Other Non Operating Income has averaged -$24727.3 across 5 years, with a median of -$5000.0 in 2021.
- The largest YoY upside for Other Non Operating Income was 290.0% in 2023 against a maximum downside of 800.0% in 2023.
- Avalo Therapeutics' Other Non Operating Income stood at -$15000.0 in 2021, then soared by 233.33% to $20000.0 in 2022, then jumped by 290.0% to $78000.0 in 2023, then sank by 106.41% to -$5000.0 in 2024, then jumped by 40.0% to -$3000.0 in 2025.
- The last three Other Non Operating Income figures came in at -$3000.0 (Q3 2025), -$5000.0 (Q2 2025), and -$5000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Avalo Therapeutics | 295.77 Mn | 295.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -5,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -120,000.00 |
| Dec 31, 2023 | 78,000.00 |
| Sep 30, 2023 | -17,000.00 |
| Mar 31, 2023 | -180,000.00 |
| Dec 31, 2022 | 20,000.00 |
| Mar 31, 2022 | -20,000.00 |
| Sep 30, 2021 | -15,000.00 |
| Jun 30, 2021 | -5,000.00 |
| Dec 31, 2020 | -38,000.00 |
| Sep 30, 2020 | 19,000.00 |
| Jun 30, 2020 | 398,000.00 |
| Mar 31, 2020 | 11,000.00 |